Get informed when a big investor buys or sells
+ FollowOvervalued by 122.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $12.63 Million |
|---|---|
| Enterprise Value | $25.17 Million |
| Earnings per Share | $-0.64 |
| Beta | 0.24 |
| Outstanding Shares | 8,069,641 |
| P/E Ratio | -1.86 |
|---|---|
| PEG | -0.2 |
| Price to Sales | - |
| Price to Book Ratio | 1.56 |
| Enterprise Value to Revenue | 6.88 |
| Enterprise Value to EBIT | -4.46 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.93 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Adapti, Inc. engages in the sale and brand development of health and beauty products. The company also acquires or licenses performing brands to add to its portfolio of products and brands. It sells cosmetics under the Dermacia brand thr...